How a Mediterranean-style diet may reduce heart failure in the aged

November 16, 2016

BIRMINGHAM, Ala. - In mouse experiments, University of Alabama at Birmingham researchers have shown how aging and excess dietary fat create signals that lead to heart failure after a heart attack.

Clarifying the mechanism of this harmful pathway is important because nearly 5 million people in the United States suffer heart failure as an age-related disease following heart attacks. Half of them die within five years, and the annual cost for health care, medications and missed work is $32 billion.

Knowledge of the dysfunctional lipid signaling that triggers heart inflammation and heart failure could be essential to discovering therapeutic treatments for the millions of aging patients at risk of heart failure after heart attacks.

The problem of heart failure is a nonresolving, overactive inflammation at the heart. After a tissue injury, such as death of muscle tissue in a heart attack, the body has a beneficial, early acute inflammation response that removes dead cells and begins repairs to the injured area. In healthy healing, the acute inflammation resolves, and a healing process follows.

In healthy healing, particular lipids that the body produces from essential dietary fat appear to act as signals to resolve the early acute inflammation, including a group of lipids called resolvins.

In contrast to such healthy healing, UAB researchers have found that a combination of age and excess omega-6 fatty acid in the mouse diet led to increased heart inflammation as compared to aged mice that ate a lower-fat, lab chow diet.

Intriguingly, the typical Western diet is much higher in the ratio of omega-6 fatty acids to omega-3 fatty acids, similar to the excess omega-6 fatty acid diet given to the mice. The so-called Mediterranean-style diet, which has much less meat, has a much lower ratio of omega-6 to omega-3 fatty acids, and people who eat a Mediterranean-style diet are known to develop less heart disease.

UAB researchers, led by Ganesh Halade, Ph.D., assistant professor in the Division of Cardiovascular Medicine, UAB Department of Medicine, report that four steps led to the nonresolving inflammation.

The aged mice that were fed with excess omega-6 fatty acid, in contrast to lean aged mice, had: 1) lower amounts of three types of lipoxygenase enzymes in the dead area of the heart muscle, enzymes that can produce resolving signal lipids such as the resolvins from dietary omega-3 fatty acids; 2) lesser amounts of resolvins and several other lipid signals that help resolve acute inflammation; 3) increased amounts of macrophage immune cells that are pro-inflammatory; and 4) increased kidney injury and increased levels of two signaling cytokines that promote inflammation -- tumor necrosis factor-alpha and interleukin-1-beta.

Thus, as Halade and colleagues report in the journal Aging, excess fatty acid intake magnifies chemokine signaling after a heart attack in aged mice, and this drives the signaling network between the heart and spleen and the heart and kidneys toward a nonresolving microenvironment.

The excess omega-6 fatty acid for the mice came from enriching their diet with safflower oil. Techniques used to elucidate the dysregulated lipid signaling pathway in the aged mice included liquid chromatography-mass spectrometry metabolipidomics to analyze lipid mediators and flow cytometry to analyze immune cells.
Besides Halade, co-authors of the paper, "Aging Dysregulates D- and E-Series Resolvins to Modulate Cardiosplenic and Cardiorenal Network Following Myocardial Infarction," are Vasundhara Kain, Ph.D., Laurence M. Black, Sumanth D. Prabhu, M.D., and Kevin A. Ingle, all of the Division of Cardiovascular Disease, UAB Department of Medicine.

At UAB, Prabhu is the Mary Gertrude Waters Chair of Cardiovascular Medicine.

University of Alabama at Birmingham

Related Heart Failure Articles from Brightsurf:

Top Science Tip Sheet on heart failure, heart muscle cells, heart attack and atrial fibrillation results
Newly discovered pathway may have potential for treating heart failure - New research model helps predict heart muscle cells' impact on heart function after injury - New mass spectrometry approach generates libraries of glycans in human heart tissue - Understanding heart damage after heart attack and treatment may provide clues for prevention - Understanding atrial fibrillation's effects on heart cells may help find treatments - New research may lead to therapy for heart failure caused by ICI cancer medication

Machining the heart: New predictor for helping to beat chronic heart failure
Researchers from Kanazawa University have used machine learning to predict which classes of chronic heart failure patients are most likely to experience heart failure death, and which are most likely to develop an arrhythmic death or sudden cardiac death.

Heart attacks, heart failure, stroke: COVID-19's dangerous cardiovascular complications
A new guide from emergency medicine doctors details the potentially deadly cardiovascular complications COVID-19 can cause.

Autoimmunity-associated heart dilation tied to heart-failure risk in type 1 diabetes
In people with type 1 diabetes without known cardiovascular disease, the presence of autoantibodies against heart muscle proteins was associated with cardiac magnetic resonance (CMR) imaging evidence of increased volume of the left ventricle (the heart's main pumping chamber), increased muscle mass, and reduced pumping function (ejection fraction), features that are associated with higher risk of failure in the general population

Transcendental Meditation prevents abnormal enlargement of the heart, reduces chronic heart failure
A randomized controlled study recently published in the Hypertension issue of Ethnicity & Disease found the Transcendental Meditation (TM) technique helps prevent abnormal enlargement of the heart compared to health education (HE) controls.

Beta blocker use identified as hospitalization risk factor in 'stiff heart' heart failure
A new study links the use of beta-blockers to heart failure hospitalizations among those with the common 'stiff heart' heart failure subtype.

Type 2 diabetes may affect heart structure and increase complications and death among heart failure patients of Asian ethnicity
The combination of heart failure and Type 2 diabetes can lead to structural changes in the heart, poorer quality of life and increased risk of death, according to a multi-country study in Asia.

Preventive drug therapy may increase right-sided heart failure risk in patients who receive heart devices
Patients treated preemptively with drugs to reduce the risk of right-sided heart failure after heart device implantation may experience the opposite effect and develop heart failure and post-operative bleeding more often than patients not receiving the drugs.

How the enzyme lipoxygenase drives heart failure after heart attacks
Heart failure after a heart attack is a global epidemic leading to heart failure pathology.

Novel heart pump shows superior outcomes in advanced heart failure
Severely ill patients with advanced heart failure who received a novel heart pump -- the HeartMate 3 left ventricular assist device (LVAD) -- suffered significantly fewer strokes, pump-related blood clots and bleeding episodes after two years, compared with similar patients who received an older, more established pump, according to research presented at the American College of Cardiology's 68th Annual Scientific Session.

Read More: Heart Failure News and Heart Failure Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to